From caveat emptor to caveat venditor : time to stop the influence of money on practice guideline development-Reference-Cited by-同舟云学术

From caveat emptor to caveat venditor : time to stop the influence of money on practice guideline development

Author:

Cosgrove Lisa¹²,Shaughnessy Allen F.³,Wheeler Emily E.¹,Krimsky Sheldon⁴⁵,Peters Shannon M.¹,Freeman-Coppadge Darren J.¹,Lexchin Joel R.⁶

Affiliation:

1. University of Massachusetts Boston; Boston MA USA

2. Edmond J. Safra Center for Ethics; Harvard University; Cambridge MA USA

3. Department of Family Medicine; Tufts University School of Medicine; Boston MA USA

4. Department of Urban and Environmental Policy and Planning; Tufts University; Malden MA USA

5. Department of Philosophy and Honors Academy; Brooklyn College; Brooklyn NY USA

6. School of Health Policy and Management; York University; Toronto Ontario Canada

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

Reference37 articles.

2. Association of funding and conclusions in randomized drug trials;Als-Nielsen;JAMA: The Journal of the American Medical Association,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Different Biometrics for Clinical Trials That Measure Volitional Control;Objective Biometric Methods for the Diagnosis and Treatment of Nervous System Disorders;2018

4. Turning the Tables;Autism;2017-09-27